NCT05889741View on ClinicalTrials.gov

Combining Stellate Ganglion Block With Prolonged Exposure for PTSD

PHASE2RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 26, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

August 31, 2027

Conditions
Stress Disorders, Post-Traumatic
Interventions
DRUG

Ropivacaine injection

6.5cc of Ropivacaine hydrochloride (HCl) 0.5%, one time into the stellate ganglion

DRUG

Normal saline

6.5cc of Normal Saline one time into the stellate ganglion.

Trial Locations (2)

76544

RECRUITING

Carl R. Darnall Army Medical Center, Fort Hood

78229

RECRUITING

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

The University of Texas Health Science Center at San Antonio

OTHER